Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline study with acceptable restrictions (limited documentation, no data on test substance purity).

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1974
Report date:
1974

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
Deviations:
yes
Remarks:
- only male animals; only three animals in negative control group; only 500 cells evaluated for mitotic index; no bone marrow toxicity in highest concentration used
GLP compliance:
no
Type of assay:
chromosome aberration assay

Test material

Constituent 1
Reference substance name:
Automatically generated during migration to IUCLID 6, no data available
IUPAC Name:
Automatically generated during migration to IUCLID 6, no data available
Details on test material:
- Name of test material (as cited in study report): synthetic silica sodium silicoaluminate (FDA 71-45)
- Physical state: fine white powder
- Analytical purity: no data

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 10-12 weeks
- Weight at study initiation: 300 to 350 g
- Housing: Rats were housed one to five per cage.
- Diet (e.g. ad libitum): commercial 4 % fat diet; periodic tests to verify the absence of coliforms, Salmonella and Pseudomonas sp. were performed.
- Water (e.g. ad libitum): water; 2 times per week water was changed
- Quarantine: 4 to 11 days
- Others: Animals were identified by ear punch. Sanitary cages and bedding were changed two times per week.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
saline (0.85 %)
Duration of treatment / exposure:
acute study: single dose (post exposure period: up to 48 hours)
subacute study: five days
Frequency of treatment:
acute study: single dose
subacute study: 5 doses, daily
Post exposure period:
acute study: sampling times 6, 24 and 48 h after administration of test substance
subacute study: animals were sacrificed 6 hours after the last dose
Doses / concentrations
Remarks:
Doses / Concentrations:
acute + subacute: 4.25, 42.5, 425 mg/kg bw
Basis:
nominal conc.
No. of animals per sex per dose:
5; only 3 animals in negative control group
acute study: 59
subacute study: 18
Control animals:
yes, concurrent vehicle
Positive control(s):
0.3 mg/kg triethylene melamine (TEM) administered intraperitoneally

Examinations

Tissues and cell types examined:
freshly isolated bone marrow cells
Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION:
The dose of 425 mg/kg corresponds to the LD5.

DETAILS OF SLIDE PREPARATION: Fixed cells were dropped on slides and dried. Slides were stained using a 5% Giemsa solution, subsequently rinsed with acetone/xylene and placed in xylene for 30 min before counting.

METHOD OF ANALYSIS:
Duplicate slides were examined microscopically. Only diploid cells were analyzed.

OTHER: 2 h prior to killing, each animal was given 4 mg/kg of colcemid intraperitoneally.

Results and discussion

Test results
Sex:
male
Genotoxicity:
negative
Toxicity:
yes
Remarks:
LD5 = 425 mg/kg
Vehicle controls validity:
valid
Negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
The compound produced no detectable significant aberration of the bone marrow metaphase chromosomes of rats when administered orally at the tested dosage levels. The test compound can be considered non-mutagenic.

Any other information on results incl. tables

acute study: The negative controls and the 3 compound-treated groups were within the normal limits of breaks observed (0 -3%). The mitotic indices were in good agreement except for the 425 mg/kg group which was slightly, but not significantly, depressed. In the positive control group 5% of the cells with severe damage (> 10 aberrations/cell) and 1% of the cells with pulverized chromosomes were observed.

Dose [mg/kg]

Sampling time [h]

Mitotic index [%]

Cells with aberrations [%]

0 (saline)

6

10

2

24

11

3

48

9

3

4.25

6

11

2

24

11

1

48

11

3

42.5

6

8

0

24

9

1

48

10

0

425

6

12

2

24

6

0

48

10

2

TEM 0.3

48

3

48

subacute study: The negative control groups and the three treated groups were within normal limits for breaks and mitotic indices.

Dose [mg/kg]

Mitotic index [%]

Cells with aberrations [%]

0 (saline)

8

3

4.25

10

2

42.5

11

2

425

8

3

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative